CN105349498B - A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine - Google Patents
A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine Download PDFInfo
- Publication number
- CN105349498B CN105349498B CN201410410197.6A CN201410410197A CN105349498B CN 105349498 B CN105349498 B CN 105349498B CN 201410410197 A CN201410410197 A CN 201410410197A CN 105349498 B CN105349498 B CN 105349498B
- Authority
- CN
- China
- Prior art keywords
- vaccine
- virus
- cell
- attenuated live
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention provides a kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine, press down cancer candidate gene 2 by being overexpressed glioma in host cell, optimization is used to prepare copying surroundings in the host cell of inactivated vaccine and/or attenuated live vaccine, improve 4 section viroids (including coronaviridae, Paramyxoviridae, orthomyxoviridae family and herpetoviridae) 1-3 lg unit of potency, the present invention provides new strategy and feasible foundation to optimize the virus titer of whole virus vaccine, field of biomedicine is with important application prospects and innovative significance.
Description
Technical field
The present invention relates to whole virus vaccine preparation fields, prepare inactivated vaccine specifically, being related to a kind of optimization and/or subtract
The method of virus live vaccine.
Background technique
Whole virus vaccine (including Attenuate vaccine and inactivated vaccine) still occupies sizable specific gravity in modern vaccination application.Entirely
Viral vaccine is otherwise known as conventional vaccine, including inactivated vaccine and attenuated live vaccine, and wherein attenuated live vaccine is using artificial fixed
Vaccine made of the microorganism of virulence height decrease or substantially nontoxic work is filtered out to the method for variation, or from nature.Subtract
After virus live vaccine inoculation, there is certain growth and breeding ability in body, immune effect is strong and lasting, general to be only inoculated with one
Secondary, immunocompetence can be kept throughout one's life, in addition to stimulation body generates cellular immunity and humoral immunity, can still generate local immunity guarantor
Shield.According to this standard, best vaccine is undoubtedly exactly living, attenuation pathogen, however dissipating poison and threatening is that it always can not
The problem of avoidance.Inactivated vaccine is to select the strong pathogenic microorganism of immunogenicity through cultivating, with either physically or chemically being gone out
After work, then purified it is made.Inactivated vaccine has lost the appeal to body, but still keeps its immunogenicity, can stimulate machine
Body generates corresponding immunity, resists the infection of street strain.Inactivated vaccine often need to be repeatedly inoculated with, and inoculation is not generated once to have and be protected
Being immunized for shield effect, only " initializes " immune system.Non- whole virus vaccine can reduce the wind of virulence reverse to the maximum extent
Danger, wherein subunit vaccine is only a small amount of antigen portion in the how species specific antigenic determinant that macromolecular antigen carries
Position plays an important role to protective immune response.Native protein is separated by protein-hydrolysis process such as chemical breakdowns, is mentioned
Viral special area is taken, is filtered out with vaccine made of immunocompetent segment.Subunit vaccine can be eliminated many unrelated anti-
Original induce antibody, thus reduce vaccine side reaction and vaccine caused by related disease.Recombinant vaccine, which refers to, utilizes DNA
Restructuring biotechnology will can induce the natural or artificial synthesized inhereditary material of immune response in pathogen coat protein
In orientation insertion bacterium, yeast or mammalian cell, be allowed to give full expression to, it is purified after prepared by vaccine.But this two
The shortcoming of class vaccine is that immunogenicity is lower, and not comprehensively, the immune effect that could have been generated need to be shared with adjuvant, therefore
Optimal protecting effect is often not achieved.
The problem that whole virus vaccine preparation field faces at present is that many production of vaccine are not high with strain potency, this is directly
Affect the effect of vaccine.By seedling poison under different preservation conditions, discovery potency titre is presented one for domestic and international some seminars
The variation for rule of establishing rules, and finally determine suitable preservation condition.There are also some seminars to improve vaccine effectiveness using immunologic adjuvant,
Such as inorganic adjuvant (aluminium hydroxide), organic adjuvant (bacterial product etc.), synthetic adjuvant (levamisol etc.), finish (Fei Shi assistant
Agent etc.) and the immunosuppressor such as ciclosporin A, rapamycin.However, the adjuvant types that country formally examines are very limited,
It does not advocate for human body, these adjuvants are mainly used for zoopery, and adjuvant disease can often occur after animal multiple injection, therefore help
The requirement of agent is very careful, is also extremely restricted.In addition, other seminars carry out strain phenotype with strain to production
Or science of heredity transformation, make it more suitable for the exploitation of Attenuate vaccine or inactivated vaccine.There are also researchers to attempt different cell lines, will such as paste
Parietal cell changes into suspension cell, to promote the potency titre of cell Proliferation virus by the cell density for increasing unit volume.
Above scheme improves the potency titre of vaccine virus to a certain extent, but there is no thin by understanding the host of virus replication in depth
Born of the same parents' factor finds and develops the intracellular resource for being conducive to virus replication.
Summary of the invention
The object of the present invention is to provide a kind of methods that optimization prepares inactivated vaccine and/or attenuated live vaccine.
In order to achieve the object of the present invention, the present invention provides glioma suppression (the Glioma tumor of cancer candidate gene 2
Suppressor candidate region gene 2, GLTSCR2) coding albumen P60 preparing inactivated vaccine and/or attenuation
Application in live vaccine, the glioma suppression cancer candidate gene 2 encode the amino acid sequence of albumen as shown in Seq ID No.1,
Or the sequence is through replacement, missing or one or several amino acids formed amino acid sequences with same function of addition.
P60 albumen is a kind of ribosomal protein P60 for being positioned at entoblast, and 4 class virus titer 1-3 can be improved
Lg unit, including it is coronavirus (such as infectious bronchitis virus), paramyxovirus (such as canine distemper and newcastle disease virus), just viscous
Viral (such as influenza virus) and herpesviral (such as herpes simplex virus and Marek's disease poison).Molecular mass is the P60 of 60kDa
Albumen and Cycle Regulation, DNA damage response and relationship with apoptosis are very close.It is reported that in DNA damage,
Nucleolin P60 can be positioned to cell caryoplasm, and in conjunction with important tumor suppressor P53, inhibit thin while stablizing P53
Intracellular growth;On the other hand, in order to cope with kernel stress, P60 albumen can block ribosomal protein in conjunction with MDM2, to promote
The degradation of P53 ubiquitination.In addition, PI3K-Akt/PKB signal pathway cell survival and in terms of all play important work
With PTEN is the main brake albumen of the access, but PTEN can degrade rapidly after P60 gene knockout, and lead to tumour.Cause
, in oncology, P60 possesses " tumor suppressor " and " roadblock for inhibiting cancer " dual identity for this.The unique biochemistry of P60
Characteristic and sophisticated functions are allowed to rapidly become scientific research hot spot, but in field of virology, rarely seen document report.
Present invention firstly discovers that P60 albumen can be functioned by several cellular pathways, such as regulation innate immune system,
Cell defense system, protein-synthesizing system.
The present invention provides a kind of method for preparing inactivated vaccine and/or attenuated live vaccine of optimization, the mistake in host cell
It expresses glioma and presses down cancer candidate gene 2, and be inoculated with host cell, training with inactivated vaccine and/or attenuated live vaccine production strain
Cell is supported, virus liquid is harvested.
The inactivated vaccine and/or attenuated live vaccine include but is not limited to coronaviridae (such as infective bronchitis disease
Poison), Paramyxoviridae (such as canine distemper and newcastle disease virus), orthomyxoviridae family (such as influenza virus) and herpetoviridae be (as single
Pure herpesviral and Marek's disease poison) etc. inactivated vaccine and/or attenuated live vaccine.
Method above-mentioned, when the convergence degree of host cell reaches 80~90%, by 1~10 TCID50Inoculation inactivation epidemic disease
Strain is used in seedling and/or attenuated live vaccine production.
The cell culture mode used in the present invention is adhere-wall culture or the culture that suspends.
The present invention also provides a kind of host cells of overexpression glioma suppression cancer candidate gene 2.
The present invention also provides above-mentioned host cells to prepare the application in inactivated vaccine and/or attenuated live vaccine.
The present invention by host cell be overexpressed coding P60 albumen gene, optimization be used to prepare inactivated vaccine and/
Or copying surroundings in the host cell of attenuated live vaccine, it is (including coronaviridae, Paramyxoviridae, just viscous to improve 4 section viroids
Viraceae and herpetoviridae) 1-3 lg unit of potency, the present invention for optimize whole virus vaccine virus titer provide new plan
Slightly with feasible foundation, field of biomedicine is with important application prospects and innovative significance.
Detailed description of the invention
Fig. 1 is characteristic and function of the p60 in virus infection host cell;Wherein, the albumen p60 of A1, two kinds of cells exist
Cellular localization when being uninfected by, it is seen that be located in nucleus;A2, after human herpes simplex vicus -1 (HSV-1) infection, it is seen that
P60 is migrated to cytoplasm;A3, after newcastle disease virus (NDV) infection, it is seen that p60 is migrated to cytoplasm;B, HSV-1 infection
(10TCID50) after Hep-2 different time, collect cell sample and carry out nucleus-matter separation, then carried out using each antibody
Western-blot analysis, it is seen that the positioning variation tendency for going out core after core occur first entering in p60 and its chaperone PTEN;C,
DNA synthetic inhibitor PMEG (+) is added in virus infection simultaneously, after different time (experiment condition and A are identical as B), it is seen that PMEG
(10 μM) will not influence the total expression of p60, but can significantly affect cellular localization, thus it is speculated that it is direct with virus replication that p60 goes out core
It is related;D is overexpressed GFP-N1 or GFP-p60 (10 μ g) after PTEN knockout 96h (800ng), and 40h postoperative infection HSV-1 is different
Time, it is seen that the knockout of PTEN acts on the enhancement of virus replication without inhibiting to be overexpressed p60, therefore p60 function and
PTEN is not fully related.
Fig. 2 is the influence for being overexpressed or knocking out 2 kinds of virus replications of p60 gene pairs in embodiment;Wherein, A1, from left to right
It is followed successively by, Hep-2 cell is overexpressed control GFP-N1 plasmid postoperative infection NDV, is overexpressed GFP-p60 plasmid postoperative infection NDV, only feels
It contaminates NDV, Hep-2 cell and knocks out (Neg) infection NDV, knockout control p60 gene postoperative infection NDV after control scramble gene, institute
With 10 μ g of plasmid, being overexpressed the time is 40 hours (A2 is same);Knockout siRNA dosage is 800ng, and the time is 96 hours (A2 is same);
Infection time is 48 hours, 10 TCID50(A2 is same) then surveys virus titer using cytopathy political reform;A2, from left to right successively
For, in addition to p60 sample is repeated 1 times (label 2-3), other sample treatments and A1 are same, virus protein N P antibody used, and 1:
1000 dilutions.It can be seen that p60 knockout is unfavorable for NDV duplication, and virus replication can then be optimized by being overexpressed;B1 is followed successively by from left to right,
Hep-2 cell be overexpressed control GFP-N1 plasmid postoperative infection HSV-1, be overexpressed GFP-p60 plasmid postoperative infection, only infection HSV-1,
Cell knocks out control scramble gene postoperative infection, knocks out control p60 gene postoperative infection, and 10 μ g of plasmid used is overexpressed the time
It is 40 hours (B2 is same);Knockout siRNA is 800ng, and the time is 96 hours (figure B2 is same);Infection time is 48 hours, 10
TCID50(B2 is same) then surveys virus titer using cytopathy political reform;B2 is followed successively by from left to right, cell infection HSV-1, crosses table
Up to control GFP-N1 plasmid postoperative infection, it is overexpressed GFP-p60 plasmid postoperative infection, cell knockout control scramble, knockout control
Scramble postoperative infection knocks out control p60, knocks out control p60 postoperative infection HSV-1.Virus protein ICP8 used and ICP0 antibody,
It is 1:1000 dilution;It can be seen that p60 knockout is unfavorable for HSV-1 duplication, and virus replication can then be optimized by being overexpressed.It can be seen that obvious poor
It is different, p < 0.01 * *.
Fig. 3 is the influence for knocking out 4 kinds of virus replications of p60 gene pairs;Wherein, primary fibroblast CEF knocks out control
Scramble gene (800ng), or control p60 gene (800ng) is knocked out, 96 hours.Then A1 infects canine distemper virus
(CDV) (10 TCID50) different time, the transcriptional level of RT-PCR method survey viral gene N, it is seen that difference, p < 0.05 *.Or it strikes
Except A2 is carried out after 96 hours, indirect immunofluorescence is observed in infection after CDV virus-4 8 hours, calculates median infective dose TCID50, it is seen that
Notable difference, p < 0.01 * *.
B, CEF cell knock out control scramble gene (800ng), or knock out control p60 gene (800ng), and 96 hours.
Then B1 infects marek virus (MDV) (10 TCID50) different time, the transcription water of RT-PCR method survey viral gene Meq
It is flat, it is seen that difference, p < 0.05 *.Or B2 is carried out after knocking out 96 hours, infection observes cytopathy after MDV virus-4 8 hours, calculates
Median infective dose TCID50, it is seen that difference, p < 0.05 *.
C, CEF cell knock out control scramble gene (800ng), or knock out control p60 gene (800ng), and 96 hours.
Then C1 infects infectious bronchitis virus (IBV) (10 TCID50) different time, then viral base is surveyed with RT-PCR method
Because of the transcriptional level of N, it is seen that difference, p < 0.05 *.Or C2 is carried out after knocking out 96 hours, it is collected after infection IBV virus-4 8 hours thin
Lesion is observed in born of the same parents, cracking for postoperative infection 9 days after instar chicken embryo, calculate chicken embryo median infective dose EID50, it is seen that difference, p < 0.05 *.
D, Vero cell knock out control scramble gene (800ng), or knock out control p60 gene (800ng), and 96 hours
Postoperative infection avian influenza virus (AIV) virus, observes cytopathy after 48 hours, calculate median infective dose TCID50, it is seen that difference, *
p<0.05。
Fig. 4 is the influence for being overexpressed p60 to 4 kinds of virus replications;Wherein primary fibroblast CEF Transfection of GFP-N1 or
GFP-p60 plasmid, each 10 μ g;A1, i.e. different time postoperative infection CDV, 10 TCID are carried out after 40 hours50, then use RT-
The transcriptional level of PCR method survey viral gene N, it is seen that after infection 6 hours, significant difference, p < 0.01 * *;Or A2, virus infection 48
Indirect immunofluorescence is observed after hour, calculates median infective dose TCID50, it is seen that difference, p < 0.05 *.
CEF cell transfecting GFP-N1 or GFP-p60 plasmid, each 10 μ g;B1, i.e. different time postoperative infection are carried out after 40 hours
MDV, 10 TCID50, the transcriptional level of viral gene Meq is then surveyed using RT-PCR method, it is seen that after infection 6 hours, difference is aobvious
It writes, p < 0.01 * *;Or B2, virus infection observe cytopathy after 48 hours, calculate median infective dose TCID50, it is seen that difference, * p
<0.05。
CEF cell transfecting GFP-N1 or GFP-p60 plasmid, each 10 μ g;C1, i.e. different time postoperative infection are carried out after 40 hours
IBV, 10 TCID50, the transcriptional level of viral gene N is then surveyed using RT-PCR method, it is seen that after infection 6 hours, difference is aobvious
It writes, p < 0.01 * *;Or C2, virus infection collected cell after 48 hours, infected instar chicken embryo on the 9th, calculated chicken embryo median infective dose
EID50, it is seen that difference, p < 0.05 *.
D, Vero cell transfecting GFP-N1 or GFP-p60 plasmid, each 10 μ g, 40 hours postoperative infection AIV virus, 10
TCID50, cytopathy is observed after 48 hours, calculates median infective dose TCID50, it is seen that difference, p < 0.05 *.
In A1, B1, C1, with 2-△△CTMethod calculates the difference of virus mRNA expression between different disposal group.Use GraphPad
Prism5 draws.The N1 processing of each time point is all standardized as 1.
Fig. 5 is the mechanism of action that p60 can optimize virus replication;Wherein, A is followed successively by from left to right, Hep-2 cell transfecting
SiRNA-negtive 200ng (40 μ l), transfection siRNA-negtive800ng (160 μ l), siRNA-p60200ng (40 μ l),
SiRNA-p60400ng (80 μ l), siRNA-p60800ng (160 μ l) are transfected, knocking out the time is 96 hours, is used before sample harvest
Poly (I:C) is stimulated 6 hours, and then RT-PCR method surveys IFN-β transcriptional level, it is seen that significant difference, p < 0.01 * *;B, sequentially with
Method is identical as A, and RT-PCR method surveys MAVS transcriptional level, significant difference, p < 0.01;C, sequentially and method is identical as A, RT-PCR
Method surveys NF- к B transcriptional level, significant difference, p < 0.01;D, sequentially and method is identical as A, and RT-PCR method surveys MDA5 transcriptional level.
Transfection knock out p60 with compare between indifference it is significant, although certain concentration dependent, p < 0.05 is presented in p60;E, sequentially with side
Method is identical as A, RT-PCR method survey RIG-1 transcriptional level, transfection knock out p60 with compare between indifference it is significant, although p60 presentation
Certain concentration dependent, p < 0.05;F is followed successively by from left to right, is uninfected by Hep-2 cell, is overexpressed control GFP-N1 matter
Grain is overexpressed GFP-p60 plasmid, is overexpressed control GFP-N1 plasmid postoperative infection HSV-1, is overexpressed GFP-p60 plasmid postoperative infection,
Each protein expression level is then surveyed using western-blot method, 10 μ g of plasmid used, being overexpressed the time is 40 hours;Infection
Time is 48 hours, 10 TCID50(E is same), as a result as it can be seen that the unfavorable albumen of p60 synthesizes (phosphorylation eIF2 α), but virus can rob
It holds and weakens this process.
Fig. 6 show pEGFP-N1 plasmid map in the embodiment of the present invention 2.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..Unless otherwise specified, embodiment
Used in the conventional means that are well known to those skilled in the art of technological means, raw materials used is commercial goods.
In following embodiment:
NDV strain is F48E9;IBV strain is H52;CDV is standard strain Snyder Hill;HSV-1 be standard poison F,
MDV strain is RB1B, and AIV is H9N2 separation poison.
The cell median infective dose and chicken embryo median infective dose of several viruses of embodiment 1
It takes 9-11 age in days SPF chicken embryo to prepare chicken embryo fibroblasts (CEF), CDV, MDV and IBV is inoculated on CEF and trained
48h is supported, cell and culture supernatant multigelation 3 times is harvested, is inoculated on CEF cell again and continues to cultivate, be so passaged to 3
Generation.By 10 doubling dilution of virus liquid, 96 orifice plate of inoculating cell or chicken embryo.CDV surveys cell median infective dose (TCID50), MDV is with carefully
TCID is surveyed in the formation of born of the same parents' lesion pox spots50, IBV chicken embryo median infective dose EID50, determine 3 kinds of viral virulence.It the results are shown in Table 1-
Table 3.
The influence (indirect immunofluorescence) of 1 CDV cell median infective dose of table
It is calculated by Reed and Muench formula: distance proportion=(the lesion rate -50 higher than 50%)/(disease higher than 50%
Variability-is lower than 50% lesion rate).TCID is calculated50=104.38/ 0.1ml, as TCID50=105.38/ml。
The influence (cytopathy political reform) of 2 MDV cell median infective dose of table
TCID is calculated50=103.70/ 0.1ml, as TCID50=104.70/ml。
The influence (chicken embryo short and smallization method) of 3 IBV chicken embryo median infective dose of table
EID is calculated50=105.5/ 0.1ml, as EID50=106.5/ml。
Similarly calculate the TCID of NDV50=2 × 109The TCID of/ml, HSV-150=108.1The TCID of/ml, AIV50=
105.4/ml。
Embodiment 2 knocks out the influence (Western blot, lesion method and RT-PCR method) with overexpression P60 to virus virulence
1, the preparation of cell
Pass on Hep-2 and Vero cell: growth-promoting media contains the DMEM culture solution of 5% fetal calf serum and 100U mycillin,
The DMEM culture solution of 2% fetal calf serum of maintaining liquid and 100U mycillin.
Primary chick embryo fibroblast (CEF) cell: instar chicken embryo is purchased from Beijing Cimmeria company within 9-10 days, and catalog number is
" SPF chicken embryo ".After 9-10 days instar chicken embryos are taken out carefully will end to end, bone and adipose tissue reject, remaining part is washed with PBS
It is cut into small pieces as far as possible after 3 times, 0.25% pancreatin is added to digest 30 minutes, 70ml culture solution is added after washing 3 times in PBS, and (growth-promoting media contains
There is a DMEM culture solution of 5% fetal calf serum and 100U mycillin, 2% fetal calf serum of maintaining liquid and 100U mycillin
DMEM culture solution), fibroblast is flushed out energetically, and culture solution containing cell crosses three layers of gauze, with 5ml/ bottles or 200 μ l/
The packing of 24 orifice plates, 37 DEG C after cell culture 24 hours (coverage rate up to 80% or more) can carry out next step experiment.
HSV and NDV infects Hep-2 cell, and AIV infects vero cell, and CDV, MDV and IBV infect CEF cell.In addition, thin
Born of the same parents' culture solution is purchased from Beijing Mai Chen company, catalog number CM15019.
2, viral proliferation
The cytotoxic proliferation of HSV, NDV, AIV and CDV: according to the amount virus inoculation stoste of cell bottle culture solution 1/10, to
Cytopathy (such as NDV forms big plasomidum) is viral using multigelation method harvest up to 75% (generally 48 hours), i.e., will be thin
Born of the same parents bottle be put into -20 DEG C freeze 2 hours after place room temperature to partial melting, yawing cell bottle makes attached cell take off wall at this time, again
It is put into -20 DEG C to freeze, 3 times repeatedly, releases virus from cell, frozen respectively at -20 DEG C and -70 DEG C.
The proliferation of the MDV virus of cell dependent antibody: its be proliferated with save the difference is that, do not use multigelation method receive
Virus is obtained, i.e., the virus of Liquid nitrogen storage is placed and is slowly melted on ice, be then inoculated with disease according to the amount of cell bottle culture solution 1/10
Toxogen liquid, when cytopathy is up to 75% (generally 48~72 hours), the digestion of 0.25% pancreatin makes attached cell take off wall, again
It is put into liquid nitrogen cryopreservation.
The proliferation of IBV embryo toxicity: 9-10 days instar chicken embryos are through the every embryonic breeding kind 10 of allantoic cavity4A TCID50Virus stock solution used, inoculation
Chicken embryo collects allantoic fluid after 140 hours, -20 DEG C or -70 DEG C freeze preservation, and IBV infection chicken embryo is not dead, but the obvious shape of chicken embryo
Body is smaller (dwarf embryo).
3, the measuring method of virus titer titre
Cytopathy (cytopathic effect, CPE) is cytopathic effect, refers to viruses into tissues culture cell
The cell degeneration generated after infecting can carry out Viral Quantification using such pathological effect.It is common that virus infection forms cytopathy
Plasomidum (maxicell that i.e. multiple cell aggregations are formed together multicore) and two kinds of plaque (cell detachment formation plaque).Lesion is melted
Conjunction rate is the ratio that sick cell accounts for all cells.
Toxicity test: obtaining cell toxicant suspension for cell toxicant doubling dilution, with 96 orifice plate culture CEF cells to single layer, to
50 hole μ L/ (including HSV, NDV, MDV and AIV) of cell toxicant suspension is added in each hole, 12 dilutions and 8 repetitions are done, in 37
Cytopathy is observed after placing 48 hours in DEG C carbon dioxide incubator, and records lesion fusion rate (lesion fusion rate i.e. lesion
Cell accounts for the ratio of all cells), it is repeated 3 times.Indirect immunofluorescence: the CFE cell culture medium that malicious CDV is cultivated 5 days will be attacked and inhaled
It abandons, after washing 3 times with PBS, after adding 4% formaldehyde fixed, is incubated for 60min with CDV mouse monoclonal antibody, is washed 3 times, added with PBS
The secondary antibody for entering the mountain sheep anti mouse of Rhodamine Red-x label is incubated for 40min, is washed 3 times with PBS.In immunofluorescence microscopy
Under 568nm wavelength, by observing and recording virus fluorescence, to carry out toxicity test.
TCID50Calculation method: virus is serially diluted, is laterally inoculated with cell monolayer plate by 96 orifice plate cell monolayers of preparation,
Every dilution repeats 3 holes, observes cytopathy daily, and viral dilution of the record higher than 50 and lower than 50% lesion hole calculates
Than away from acquisition TCID50As a result.Calculation formula are as follows: (the lesion rate -50% higher than 50%)/(higher than 50% lesion rate-it is less than
50% lesion rate)=than away from;Than just obtaining index away from being added with the index of the dilution of the virus close to 50% lesion rate.
For example, colorimetric calculates or the TCID of micro- sem observation virus5010-7~10-8Between, then, index -8 with than obtaining away from being added
The new index obtained, as TCID50Index.
IBV toxicity test: 9-10 days instar chicken embryos are through allantoic cavity virus inoculation solution, every 1 μ L of egg inoculation (1 μ L virus
The virus quantity contained in solution is 104A TCID50Unit) viral solution, inoculated into chick embryo collects allantoic fluid after 48-72 hours, see
Examine chicken embryo lesion.As a result, the pathological condition that chicken embryo body becomes smaller is presented in chicken embryo, (body trunk portion length is about normal control chicken
The 2/3 of idiosome product), it is contemplated that hereafter the situation of virus often high titre infection in actual production is tested all using this viral dilution
Degree.
4, real-time quantitative RT-PCR method and the primer
The design of primer: according to the viral protein gene sequence delivered in GenBank, such as CDV-N albumen, MDV-meq
Albumen, IBV-N protein sequence carry out nucleotide homology analysis using molecular biology software DNAStar, select virus replication
Target sequence of the relevant gene conserved sequence as PCR amplification.Fluorescence PCR primer design principle is followed, it is soft with Primer 5.0
Part separately designs primer (table 4).
Real-time quantitative PCR: siRNAP60 and siNeg are transfected to CEF 96h, during which by N1, P60 plasmid transfection to CEF
After upper 40h, virus inoculation extracts total serum IgE according to Trizol lysate specification 3 after connecing poison, 6,12,24,48h receipts cell.
Specific downstream primer is used to carry out the synthesis of cDNA as reverse transcription primer.Real-time quantitative is carried out with SYBR Green I dye method
PCR amplification.20 μ L overall reaction systems: 10 μ 2 × SYBR of L Green I PCR mix, each 0.4 μ L of upstream and downstream primer (10 μM),
Moisturizing is to 20 μ L.Real-Time PCR System (ViiA7) sets response procedures: 95 DEG C of initial denaturation 5min, is denaturalized 95 DEG C
10s, 60 DEG C of annealing and extension 45s, set 40 circulations, finally carry out melting curve analysis.Take 2-ΔΔtMethod, to target gene
Relative quantification is carried out, β-actin is selected as reference gene.
4 primer sequence information of table
5, gene knockout step
Cell transfecting: taking the SPF chicken embryo of 9-11 age in days to prepare CEF or passage cell Hep-2 and Vero, cell density extremely
After 50%, siRNAP60 and siNeg (each 800ng) are distinguished according to (invitrogen) specification of lipofectamine 2000
Transfect 96h.Target P60 gene specific small RNA fragments Sip60, and the Neg without selectively targeted any cell protein sequence
(or scramble) is purchased from sub- novacine object limited liability company (Abnova).
Virus inoculation: Transfected cells distinguish virus infection, the equal 10TCID of every kind of virus50, cultivate different time.
6, it is overexpressed
Cell transfecting: CEF, Hep-2 or Vero cell reach 80% to cell density, according to lipofectamine
2000 specifications transfect eukaryon expression plasmid pEGFP-P60 and its carrier (pEGFP-N1) respectively, the equal 10 μ g of every kind of plasmid,
It is overexpressed 40h.
The construction method of pEGFP-P60 plasmid are as follows: extract Vero cell total rna, with 5'-ATGGCGGCAGGAGGC-3' with
5'-CAACTGGATCTCACG-3' is upstream and downstream primer, and reverse transcription obtains P60cDNA, carries out PCR amplification, PCR amplification is produced
Object adds restriction enzyme site EcoRI and BamHI respectively;The carrier pEGFP-N1 that can stablize expression GFP is selected simultaneously, in the upstream EGFP
Select restriction enzyme site EcoRI and BamHI.It is connected after p60 gene is distinguished double digestion with pEGFP-N1 carrier, building obtains
PEGFP-P60 plasmid.Plasmid pEGFP-N1 map is shown in Fig. 6.
Virus inoculation: Transfected cells distinguish virus infection, the equal 10TCID of every kind of virus50, cultivate different time.
7, Western blot, lesion method and RT-PCR method research P60 are overexpressed or knock out the influence to virus virulence
Immunoblotting: the pH7.5PBS for step 5, in 6 knocking out or being overexpressed the cell pre-cooling for handling and infecting is washed 3 times
Afterwards, cell scraper scrapes, and behind total protein of cell 3-5 seconds that ultrasound cracking is extracted, mixes, boils with 6x SDS-PAGE sample-loading buffer
10min is boiled, SDS-PAGE electrophoresis is carried out, is transferred to the albumen on gel on pvdf membrane by electric transferring film instrument after electrophoresis.Containing 5%
The PBST buffer room temperature of skimmed milk power closes lh, and 4 DEG C of shakes of primary antibody is added to be incubated for 2h.Film 4x5min is washed with PBST, l:8000 is dilute
The corresponding secondary antibody room temperature for releasing HRP label, which is shaken, is incubated for 1h, washes film 4x5min, finally uses SuperSignal West Pico
Chemilumineseent HRPSubstrate ECL colour developing, and with Kodak's medical film exposure, last developing fixing is seen
It examines.Wherein antibody: virus protein antibody is purchased from Santa Cruz biotech company (Santa Cruz Biotechnology).
It is that century biotechnology has that the fluorescence of Red-x containing Rhodamine goat anti-mouse lgG secondary antibody, which is purchased from Beijing health with other secondary antibodies,
Limit company.Virus protein antibody used, including ICP8, ICP0, NP antibody and p60 antibody and actin antibody, are 1:
1000 dilutions.See Fig. 2A 2 and B2.It is replicated it can be seen that p60 knockout is unfavorable for HSV-1 and NDV, and both diseases can then be optimized by being overexpressed
The duplication of poison.
Lesion tests (TCID50/EID50): the cell sample difference for handling and infecting is knocked out or is overexpressed by step 5, in 6
It collects, wherein MDV is digested with 0.25% pancreatin, other virus infected cells are using multigelation method harvest virus, i.e., will be thin
Born of the same parents bottle be put into -20 DEG C freeze 2 hours after place room temperature to partial melting, yawing cell bottle makes attached cell take off wall at this time, again
It is put into -20 DEG C to freeze, 3 times repeatedly, releases virus from cell.It, need to be -70 if all samples do not have to temporarily
DEG C or liquid nitrogen in freeze.Then carry out, 1) cytopathy analysis: by the Hep-2 cell of HSV and NDV infection, AIV infects vero
Cell, MDV infect the sample of CEF cell, carry out doubling dilution and obtain cell toxicant suspension, with 96 orifice plate culture CEF cells to list
50 hole μ L/ (including HSV, NDV, MDV and AIV) of cell toxicant suspension is added into each hole, does 12 dilutions and 8 repetitions for layer,
Cytopathy is observed after placing 48 hours in 37 DEG C of carbon dioxide incubators, and calculates TCID50(form the virus of cytopathy
Titre), it is repeated 3 times.In addition, immunofluorescence analysis: the CFE cell culture medium of CDV infection, which is inhaled, to be abandoned, and after washing 3 times with PBS, adds 4%
Formaldehyde it is fixed after, be incubated for 60min with CDV mouse monoclonal antibody, washed 3 times with PBS, Rhodamine Red-x label is added
Mountain sheep anti mouse secondary antibody be incubated for 40min, washed 3 times with PBS.Under immunofluorescence microscopy 568nm wavelength, by observing and recording
Virus fluorescence, to carry out toxicity test and calculate TCID50。2)EID50Analysis: the cell sample of IBV will be infected, 10 multiple proportions are dilute
It releases, is inoculated with SPF chicken embryo, every 1 μ L of egg inoculation measures IBV chicken embryo median infective dose EID50, according to Reed-Muench formula
It calculates and determines above-mentioned 6 kinds of viral virulence.See Fig. 2A 1 and B1;Fig. 3 A2, B2, C2, D;Fig. 4 A2, B2, C2, D.
Real-time quantitative RT-PCR: by step 5, the cell sample infected in 6 is collected respectively, is said according to Trizol lysate
Bright book extracts total serum IgE.Specific downstream primer is used to carry out the conjunction of cDNA as reverse transcription primer (using primer shown in step 4)
At.Real-time quantitative PCR amplification is carried out with SYBR Green I dye method.20 μ L overall reaction systems: 10 μ 2 × SYBR of L Green
I PCR mix, each 0.4 μ L of upstream and downstream primer (10 μM), moisturizing to 20 μ L.Real-Time PCR System (ViiA 7) setting
Response procedures: 95 DEG C of initial denaturation 5min are denaturalized 95 DEG C of 10s, 60 DEG C of annealing and extension 45s, set 40 circulations, finally melted
Solution curve analysis.Take 2-ΔΔtMethod carries out relative quantification to target gene, and β-actin is selected as reference gene.See Fig. 3 A1, B1,
C1;Fig. 4 A1, B1, C1.
8, immunoblotting, cell/chicken embryo lesion and RT-PCR method eligible result
Wherein immunoblotting partial results (HSV and NDV) are shown in Fig. 2.
Influence (RT-PCR method) about knockout p60 albumen to virus replication: CDV (tests average value) three times: RT-PCR
The sip60 processing group measured is respectively as follows: 1.23,2.76,47.25 in 12,24,48 hours.The siNeg processing group that RT-PCR is measured,
12, it is respectively as follows: 2.97,11.13,173.0 within 24,48 hours.MDV (tests average value) three times: the sip60 processing that RT-PCR is measured
Group is respectively as follows: 5.52,16.71,180.79 in 12,24,48 hours.The siNeg processing group that RT-PCR is measured, 12,24,48 hours
It is respectively as follows: 11.39,45.47,429.56.IBV (tests average value) three times: the sip60 processing group that RT-PCR is measured, 12,24,
It is respectively as follows: 15.15,32.5,91.2 within 48 hours.The siNeg processing group that RT-PCR is measured is respectively as follows: 29.9 in 12,24,48 hours,
86.5 205.6.
About influence (RT-PCR method) of the overexpression p60 albumen to virus replication: after visible infection 6 hours, difference is aobvious
It writes, p < 0.01 * *.In Fig. 4 A1, B1, C1, with 2-△△CTMethod calculates the difference of virus mRNA expression between different disposal group.With
GraphPad prism5 draws.The N1 processing of each time point is all standardized as 1.Because gap is obvious, specific number is not arranged
Out.
Influence (TCID about 60 albumen of overexpression to virus replication50Method):
CDV----N1 processing group is TCID50=105.58/ ml, P60 TCID50=106.70/ml。
HSV----N1 is TCID50=108.3/ ml, P60 TCID50=1010.52/ml。
NDV----N1 is TCID50=108.6/ ml, P60 TCID50=1010.58/ml。
MDV---N1 is TCID50=104.29/ ml, P60 TCID50=105.60/ml。
IBV---N1 is EID50=106.5/ ml, P60 EID50=107.5/ml。
AIV---N1 is TCID50=105.2/ ml, P60 TCID50=107.1/ml。
To sum up, N1 and P60 is overexpressed to TCID after virus infection50Influence difference between Ig 1-3, gap is obvious.
Influence (TCID about 60 albumen of knockout to virus replication50Method):
CDV----N1 processing group is TCID50=106.38/ ml, P60 TCID50=104.58/ml。
HSV----N1 is TCID50=108.63/ ml, P60 TCID50=106.32/ml。
NDV----N1 is TCID50=108.92/ ml, P60 TCID50=106.78/ml。
MDV---N1 is TCID50=105.25/ ml, P60 TCID50=104.25/ml。
IBV---N1 is EID50=107.5/ ml, P60 EID50=106.25/ml。
AIV---N1 is TCID50=105.32/ ml, P60 TCID50=104.1/ml。
To sum up, N1 and P60 is knocked out to TCID after virus infection50Influence difference between Ig 1-3, gap is obvious.
Result of study further proves that p60 albumen can optimize paramyxovirus, coronavirus, orthomyxovirus and herpesviral
Duplication.
Fig. 1 is characteristic and function of the p60 in virus infection host cell, and Fig. 5 is the effect that p60 can optimize virus replication
Mechanism.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, fall within the scope of the claimed invention without departing from theon the basis of the spirit of the present invention.
Claims (5)
1. glioma suppression cancer candidate gene 2 encode albumen preparing the application in inactivated vaccine and/or attenuated live vaccine, be by
After the gene is overexpressed in host cell, then transfected virus culture;
Wherein, the glioma suppression cancer candidate gene 2 encodes the amino acid sequence of albumen as shown in Seq ID No.1;
The host cell is CEF, Hep-2, Vero;The inactivated vaccine and/or attenuated live vaccine are coronaviridae, pair is viscous
The inactivated vaccine and/or attenuated live vaccine of Viraceae, orthomyxoviridae family and herpetoviridae.
2. the inactivated vaccine and/or attenuated live vaccine preparation method of a kind of optimization, which is characterized in that be overexpressed in host cell
Glioma presses down cancer candidate gene 2, and is inoculated with host cell with inactivated vaccine and/or attenuated live vaccine production strain, and culture is thin
Born of the same parents harvest virus liquid;
Wherein, the definition of the glioma suppression cancer candidate gene 2, host cell and inactivated vaccine and/or attenuated live vaccine is same
Described in claim 1.
3. according to the method described in claim 2, it is characterized in that, when the convergence degree of host cell reaches 80~90%, by 1
~10 TCID50Strain is used in inoculation inactivated vaccine and/or attenuated live vaccine production.
4. according to the method described in claim 2, it is characterized in that, cell culture mode is adhere-wall culture or the culture that suspends.
5. the host cell for being overexpressed glioma suppression cancer candidate gene 2 is preparing answering in inactivated vaccine and/or attenuated live vaccine
With;
Wherein, the definition of the glioma suppression cancer candidate gene 2, host cell and inactivated vaccine and/or attenuated live vaccine is same
Described in claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410410197.6A CN105349498B (en) | 2014-08-19 | 2014-08-19 | A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410410197.6A CN105349498B (en) | 2014-08-19 | 2014-08-19 | A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105349498A CN105349498A (en) | 2016-02-24 |
CN105349498B true CN105349498B (en) | 2019-02-19 |
Family
ID=55325562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410410197.6A Expired - Fee Related CN105349498B (en) | 2014-08-19 | 2014-08-19 | A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105349498B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107043426B (en) * | 2016-02-05 | 2020-01-24 | 中国农业大学 | Fusion protein 210 and its use in optimizing viral replication |
-
2014
- 2014-08-19 CN CN201410410197.6A patent/CN105349498B/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
glioma tumor suppressor candidate region protein 2 [Homo sapiens](GenBank: AAF62873.1);Smith,J.S.,et al;《NCBI》;20000406 |
Moesin–ezrin–radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus;Hongbo Chen,et al;《The International Journal of Biochemistry & Cell Biology》;20101215;第43卷;545-555 |
Nucleolar Localization of GLTSCR2/PICT1 is Mediated by Multiple Unique Nucleolar Localization Sequences;Inna Kalt,et al;《PLOS ONE》;20120123 |
Also Published As
Publication number | Publication date |
---|---|
CN105349498A (en) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shah et al. | Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome | |
Bello et al. | Diagnostic and vaccination approaches for Newcastle disease virus in poultry: The current and emerging perspectives | |
Luo et al. | Porcine deltacoronavirus (PDCoV) infection suppresses RIG-I-mediated interferon-β production | |
CN103370079B (en) | For the herpes turkey virus of bird flu in poultry as the vaccine of carrier | |
Li et al. | Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens | |
He et al. | The use of an in vitro microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against Grass carp reovirus | |
CN103451158A (en) | Materials and methods for respiratory disease control in canines | |
CN105255910A (en) | Vaccine composition against pig pseudorabies viruses and preparation method and application thereof | |
CN109439634A (en) | Pseudorabies virus genetic engineering attenuated vaccine strain and its application | |
Ge et al. | Generation and evaluation of a newcastle disease virus–based H9 avian influenza live vaccine | |
Zhang et al. | Protection conferred by a recombinant Marek’s disease virus that expresses the spike protein from infectious bronchitis virus in specific pathogen-free chicken | |
Qin et al. | Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine | |
Liu et al. | Generation and functional evaluation of a DNA vaccine co-expressing Cyprinid herpesvirus-3 envelope protein and carp interleukin-1 beta | |
Tan et al. | Infectious bronchitis virus poly-epitope-based vaccine protects chickens from acute infection | |
CN103468651A (en) | Recombination Newcastle vaccine strain rAI4-S1 for expressing infectious bronchitis virus S1 protein and generating method thereof | |
Tarpey et al. | Safety and efficacy of an infectious bronchitis virus used for chicken embryo vaccination | |
KR101732240B1 (en) | Infectious bronchitis vaccines derived from ib qx-like strains | |
Liu et al. | Infectious bronchitis virus nucleoprotein specific CTL response is generated prior to serum IgG | |
Lin et al. | Deletion of the Infectious spleen and kidney necrosis virus ORF069L reduces virulence to mandarin fish Siniperca chuatsi | |
Wang et al. | Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNγ | |
Liu et al. | Altered pathogenicity, immunogenicity, tissue tropism and 3′-7 kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos | |
CN105349498B (en) | A kind of method that optimization prepares inactivated vaccine and/or attenuated live vaccine | |
CN109136198A (en) | A kind of expression Chicken Infectious Anemia Virus VP1, VP2 genetic recombination bird pox virus live vector vaccine | |
CN105802921B (en) | Recombinant pseudorabies virus variant strain for expressing classical swine fever virus E2protein and construction method and application thereof | |
Bourogâa et al. | Evaluation of protection conferred by a vaccination program based on the H120 and CR88 commercial vaccines against a field variant of avian infectious bronchitis virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190219 Termination date: 20190819 |